Michael Saylor: AI Helped Strategy Raise $15 Billion for Bitcoin

MicroStrategy executive chairman Michael Saylor has revealed that artificial intelligence played a crucial role in the company's recent capital-raising efforts. Saylor stated that he utilized AI, including ChatGPT, to design a novel class of preferred stocks that ultimately enabled MicroStrategy to secure approximately $15 billion. This capital infusion is intended to further bolster the company's extensive Bitcoin holdings.
The move towards AI-assisted financial innovation came as MicroStrategy's traditional financing methods, such as common stock sales and convertible bonds, began to reach their scalability limits. Saylor explained that the company had already maximized its use of these instruments for its initial Bitcoin accumulation phase. To continue its aggressive strategy, MicroStrategy needed to create a new type of security capable of generating substantial funds.
Saylor described how he prompted an AI to explore the structuring of variable-dividend preferred stocks. This process led to the development of securities, including one type that raised about $10.5 billion and related products that added another $4 billion. These instruments were designed with unique features, such as adjustable dividend rates to maintain stability, which initially met skepticism from conventional financial advisors due to their unprecedented nature.
By the numbers
Daily close, August 9, 2026 ยท Data: CoinGecko
This is an AI-assisted summary. Original reporting by CryptoSlate.
Read the originalRelated stories

Nvidia Adds AI Agent Safety Controls
Nvidia introduces hardware-based safety features for AI agents, aiming to prevent unauthorized actions and breaches following recent incidents.

AI Slashes Quantum-Safe Bitcoin Transaction Cost
Artificial intelligence dramatically reduced the estimated cost for a quantum-safe Bitcoin transaction, from $320 to $66, in just one week of development.

AI Discoveries: Claude Uncovers Novel Enzyme System
AI model Claude has autonomously identified a potential new gene-editing enzyme system, though its function remains unknown. Experts are evaluating the